BG vs JAZZ · P/E 31, rev $23.76B vs P/E 1988, rev $2.28B
Bunge Global SA (BG) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Bunge Global SA (BG) is a farm products company listed on NYSE.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported BG revenue for 2025-12-31 was $23.76B. Net income was $95.0M. Revenue was up 75.5% from 2024-12-31 to 2025-12-31. BG currently screens at market cap $22.53B and trailing P/E 30.6.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
BG currently screens at market cap $22.53B and trailing P/E 30.6. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the BG and JAZZ stock pages for the full models.
Not investment advice.